108 related articles for article (PubMed ID: 24879892)
1. Is screen-and-treat approach suited for screening and management of precancerous cervical lesions in Sub-Saharan Africa?
Fokom-Domgue J; Vassilakos P; Petignat P
Prev Med; 2014 Aug; 65():138-40. PubMed ID: 24879892
[TBL] [Abstract][Full Text] [Related]
2. Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.
Chamot E; Kristensen S; Stringer JS; Mwanahamuntu MH
BMC Womens Health; 2010 Apr; 10():11. PubMed ID: 20359354
[TBL] [Abstract][Full Text] [Related]
3. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
4. Screening and management of precancerous lesions to prevent cervical cancer in low-resource settings.
Sellors J; Lewis K; Kidula N; Muhombe K; Tsu V; Herdman C
Asian Pac J Cancer Prev; 2003; 4(3):277-80. PubMed ID: 14507251
[TBL] [Abstract][Full Text] [Related]
5. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
6. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
7. Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa.
Metaxas T; Kenfack B; Sormani J; Tincho E; Lemoupa Makajio S; Wisniak A; Vassilakos P; Petignat P
BMC Cancer; 2022 Feb; 22(1):132. PubMed ID: 35109806
[TBL] [Abstract][Full Text] [Related]
8. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.
Pfaendler KS; Mwanahamuntu MH; Sahasrabuddhe VV; Mudenda V; Stringer JS; Parham GP
Gynecol Oncol; 2008 Sep; 110(3):402-7. PubMed ID: 18556050
[TBL] [Abstract][Full Text] [Related]
9. New technologies in cervical cancer screening.
Gravitt PE; Coutlée F; Iftner T; Sellors JW; Quint WG; Wheeler CM
Vaccine; 2008 Aug; 26 Suppl 10():K42-52. PubMed ID: 18847556
[TBL] [Abstract][Full Text] [Related]
10. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
11. Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries.
Mvundura M; Tsu V
Int J Gynaecol Obstet; 2014 Aug; 126(2):151-5. PubMed ID: 24792401
[TBL] [Abstract][Full Text] [Related]
12. Screening for cervical cancer: recommendation statement.
U.S. Preventive Services Task Force
Am Fam Physician; 2012 Sep; 86(6):555-9. PubMed ID: 23062047
[No Abstract] [Full Text] [Related]
13. Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
Shin MB; Oluoch LM; Barnabas RV; Baynes C; Fridah H; Heitner J; Kerubo MB; Ngure K; Pinder LF; Thomas KK; Mugo NR; Gimbel S
Implement Sci; 2023 Jun; 18(1):26. PubMed ID: 37365575
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer: the sub-Saharan African perspective.
Anorlu RI
Reprod Health Matters; 2008 Nov; 16(32):41-9. PubMed ID: 19027621
[TBL] [Abstract][Full Text] [Related]
16. Management of cervical precancers: a global perspective.
Echelman D; Feldman S
Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
[TBL] [Abstract][Full Text] [Related]
17. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
Oncologist; 2013; 18(12):1278-84. PubMed ID: 24217554
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
Louie KS; de Sanjose S; Mayaud P
Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature.
McClung EC; Blumenthal PD
Minerva Ginecol; 2012 Apr; 64(2):149-71. PubMed ID: 22481625
[TBL] [Abstract][Full Text] [Related]
20. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
